Correction: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines.
| Autor: | Siddiqui M; Neurology, St. George's University, True Blue, GRD.; Neurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Shah PV; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Balani P; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Lopez AR; Psychiatry, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Nobleza CMN; Neurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Khan S; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2021 Feb 12; Vol. 13 (2), pp. c41. Date of Electronic Publication: 2021 Feb 12. |
| DOI: | 10.7759/cureus.c41 |
| Abstrakt: | [This corrects the article DOI: 10.7759/cureus.13002.]. Competing Interests: No competing interests declared. (Copyright © 2021, Siddiqui et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|